BYDFi Launches Innovative Perpetual Contract Copy Trading Feature, Welcomes Global Traders to Join
Victoria, Seychelles, January 13th, 2025, Chainwire BYDFi, a global leader in cryptocurrency trading, announces the launch of its innovative Perpetual Contract Copy Trading...
Read More3 Bitcoin Price Scenarios That Could Shape 2025 Unveiled by Peter Brandt
U.Today - The beginning of the new year 2025 can hardly be called prosperous for the cryptocurrency market. First, the price of Bitcoin (BTC) teased us with a new all-time high...
Read MoreMark Zuckerberg joined Nvidia's CEO in doubting quantum computing — and the stocks plunge again
Quantum computing stocks are plunging again after another major tech leader cast doubts on the technology’s usefulness in the near future.
Read MoreAmerican Electric Power Is Attractive Going Forward, Analyst Double-Upgrades Stock
BofA Securities analyst Ross Fowler upgraded the shares of American Electric Power Company Inc (NASDAQ:AEP) from Underperform to Buy and raised the price target from $98 to $104. The analyst upgraded the stock after the company announced the sale of a 19.9% minority stake in its transmission holding assets for $2.8 billion, along with the appointment of Trevor Mihalik as CFO. The analyst sees the asset sale as a strategic move to meet external equity needs and expect AEP to continue addressing t
Read MoreHow DeFi is bringing new opportunities and challenges to traditional markets
DeFi is transforming finance, offering inclusivity and innovation while posing new challenges for investors.
Read MoreCancer-Focused Phio Pharmaceuticals Stock Gains 300% On Monday - Here's Why
On Monday, Phio Pharmaceuticals Corp. (NASDAQ:PHIO) stock skyrocketed with a strong session volume of 201.04 million, compared to the average volume of 362.72k, according to data from Benzinga Pro. Phio reported pathologic responses for patients enrolled in the 2nd cohort, which includes two patients with a complete response or 100% tumor clearance. Phio’s ongoing Phase 1b clinical study is designed to evaluate the safety and tolerability of neoadjuvant use of intratumoral PH-762 in Stages 1, 2
Read MoreUS Steel Stock Jumps as Cleveland-Cliffs and Nucor Reportedly Mull Joint Bid
U.S. Steel shares jumped Monday on a report that Cleveland-Cliffs is teaming up with rival Nucor for a potential bid for the company, whose $14.1 billion buyout by Nippon Steel was recently blocked by President Joe Biden.
Read MoreTraders Brace for Biggest S&P Earnings-Day Reactions Ever
(Bloomberg) -- Traders are bracing for one of the most volatile earnings periods in stock market history.Most Read from BloombergThese Homes Withstood the LA Fires. Architects Explain WhyA Blueprint for Better Bike LanesWhat Robotaxis Brought San FranciscoAmbitious High-Speed Rail Plans Advance in the Baltic RegionAt least that’s what they are positioning for two days before big banks kick off the reporting cycle in the US. Options traders expect individual stocks in the S&P 500 Index to move 4.
Read MoreUS IPO Market Rebound Faces a Reality Check as Yields Spike
(Bloomberg) -- Dealmakers, who were gearing up for a busy year of initial public offerings, have already been confronted by a formidable challenge: rising Treasury yields that could deflate enthusiasm for new listings.Most Read from BloombergThese Homes Withstood the LA Fires. Architects Explain WhyA Blueprint for Better Bike LanesWhat Robotaxis Brought San FranciscoAmbitious High-Speed Rail Plans Advance in the Baltic RegionUS IPO volume in 2025 was expected to return to prepandemic levels afte
Read MoreTop Stock Movers Now: Moderna, Macy's, Valero Energy, and More
U.S. equities were mixed at midday, with the Nasdaq losing more than 1% on worries about future Federal Reserve interest-rate cuts.
Read MoreWhat Analysts Think of JPMorgan Chase Stock Ahead of Earnings
JPMorgan Chase is scheduled to report earnings before the opening bell Wednesday, kicking off a stretch of earnings reports as America's largest financial institutions wrap up their 2024s.
Read MoreModerna's $1 Billion Revenue Forecast Cut Sends Stock Plummeting Over 20%
Moderna shares plunged Monday after the company cut its 2025 revenue forecast by $1 billion.
Read MoreMacy's Stock Sinks as It Warns Underperforming Stores Will Hurt Results
Macy's said its fourth-quarter results would be pulled down by poor performance by some of its stores.
Read MoreEthereum ‘Verge’ upgrade to enable nodes on phones and smartwatches
Ethereum co-founder Vitalik Buterin said the network’s next upgrade, called “The Verge,” is designed to …
Read MoreAbercrombie & Fitch Lifts Its Outlook—And Its Stock Drops
Apparel retailer Abercrombie & Fitch lifted its end-of-year outlook today, but its shares were down nearly 20% in recent trading.
Read More